Moving from unsequenced to sequenced genome: Reanalysis of the proteome of Leishmania donovani

Journal of Proteomics

Volumn 97, Issue , 2014, Pages 48-61

  Nirujogi, Raja Sekhar ^a,b   Pawar, Harsh ^a,c   Renuse, Santosh ^a,d   Kumar, Praveen ^a   Chavan, Sandip ^a,e   Sathe, Gajanan ^a,e   Sharma, Jyoti ^a,e   Khobragade, Sweta ^f   Pande, Janhavee ^f   Modak, Bhakti ^f   Prasad, T S Keshava ^a,b,e   Harsha, H C ^a   Patole, Milind S ^f   Pandey, Akhilesh ^g  

^a INSTITUTE OF BIOINFORMATICS   (India)

^b PONDICHERRY UNIVERSITY   (India)

^c RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES   (India)

^d AMRITA UNIVERSITY   (India)

^e MANIPAL UNIVERSITY   (India)

^f NATIONAL CENTRE FOR CELL SCIENCE   (India)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Digenic parasite; Genome annotation; High resolution mass spectrometry; Intracellular pathogen

Indexed keywords

PROTEOME; MEMBRANE PROTEIN; PEPTIDE; VIRULENCE FACTOR;

AMASTIGOTE; ARTICLE; GENE IDENTIFICATION; GENE SEQUENCE; LEISHMANIA DONOVANI; LEISHMANIASIS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; PROTEOMICS; GENE ONTOLOGY; GENOME; GENOME ANALYSIS; PROTEIN ANALYSIS; PROTEIN DATABASE; SURVIVAL FACTOR;

KINETOPLASTIDA; LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; NASO HEXACANTHUS; PROTOZOA;

DIGENIC PARASITE; FALSE DISCOVERY RATE; FDR; GENOME ANNOTATION; GENOME SEARCH SPECIFIC PEPTIDES; GSSPS; HCD; HIGH ENERGY COLLISION INDUCED DISSOCIATION; HIGH RESOLUTION MASS SPECTROMETRY; INTRACELLULAR PATHOGEN; PEPTIDE SPECTRUM MATCHES; PSM;

DATABASES, PROTEIN; GENES, PROTOZOAN; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; PEPTIDES; PROTEOME; PROTOZOAN PROTEINS;

EID: 84892863715     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.04.021     Document Type: Article

References (81)

1. WHO Leishmaniasis: burden of disease, surveillance e control, epidemics, access to medicines, information resources 2010, World Health Organization.
2. Killick-Kendrick R. Phlebotomine vectors of the leishmaniases: a review. Med Vet Entomol 1990, 4:1-24.
3. Murray H.W., Berman J.D., Davies C.R., Saravia N.G. Advances in leishmaniasis. Lancet 2005, 366:1561-1577.
4. Berman J. Visceral leishmaniasis in the New World & Africa. Indian J Med Res 2006, 123:289-294.
5. Alvar J., Aparicio P., Aseffa A., Den Boer M., Canavate C., Dedet J.P., et al. The relationship between leishmaniasis and AIDS: the second 10years. Clin Microbiol Rev 2008, 21:334-359. [table of contents].
6. Downing T., Imamura H., Decuypere S., Clark T.G., Coombs G.H., Cotton J.A., et al. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res 2011, 21:2143-2156.
7. Ivens A.C., Peacock C.S., Worthey E.A., Murphy L., Aggarwal G., Berriman M., et al. The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309:436-442.
8. Peacock C.S., Seeger K., Harris D., Murphy L., Ruiz J.C., Quail M.A., et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 2007, 39:839-847.
9. Rogers M.B., Hilley J.D., Dickens N.J., Wilkes J., Bates P.A., Depledge D.P., et al. Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res 2011, 21:2129-2142.
10. Dujardin J.C. Structure, dynamics and function of Leishmania genome: resolving the puzzle of infection, genetics and evolution?. Infect Genet Evol 2009, 9:290-297.
11. Mann M., Pandey A. Use of mass spectrometry-derived data to annotate nucleotide and protein sequence databases. Trends Biochem Sci 2001, 26:54-61.
12. Pandey A., Mann M. Proteomics to study genes and genomes. Nature 2000, 405:837-846.
13. Pandey A., Lewitter F. Nucleotide sequence databases: a gold mine for biologists. Trends Biochem Sci 1999, 24:276-280.
14. Yates J.R., Eng J.K., McCormack A.L. Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases. Anal Chem 1995, 67:3202-3210.
15. Choudhary J.S., Blackstock W.P., Creasy D.M., Cottrell J.S. Interrogating the human genome using uninterpreted mass spectrometry data. Proteomics 2001, 1:651-667.
16. Menon R., Zhang Q., Zhang Y., Fermin D., Bardeesy N., DePinho R.A., et al. Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer. Cancer Res 2009, 69:300-309.
17. Molina H., Bunkenborg J., Reddy G.H., Muthusamy B., Scheel P.J., Pandey A. A proteomic analysis of human hemodialysis fluid. Mol Cell Proteomics 2005, 4:637-650.
18. Desiere F., Deutsch E.W., Nesvizhskii A.I., Mallick P., King N.L., Eng J.K., et al. Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol 2005, 6:R9.
19. Fermin D., Allen B.B., Blackwell T.W., Menon R., Adamski M., Xu Y., et al. Novel gene and gene model detection using a whole genome open reading frame analysis in proteomics. Genome Biol 2006, 7:R35.
20. Chaerkady R., Kelkar D.S., Muthusamy B., Kandasamy K., Dwivedi S.B., Sahasrabuddhe N.A., et al. A proteogenomic analysis of Anopheles gambiae using high-resolution Fourier transform mass spectrometry. Genome Res 2011, 21:1872-1881.
21. Kalume D.E., Peri S., Reddy R., Zhong J., Okulate M., Kumar N., et al. Genome annotation of Anopheles gambiae using mass spectrometry-derived data. BMC Genomics 2005, 6:128.
22. Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K., et al. Proteogenomic analysis of Mycobacterium tuberculosis by high resolution mass spectrometry. Mol Cell Proteomics 2011, 10:1-12.
23. Prasad T.S., Harsha H.C., Keerthikumar S., Sekhar N.R., Selvan L.D., Kumar P., et al. Proteogenomic analysis of Candida glabrata using high resolution mass spectrometry. J Proteome Res 2012, 11:247-260.
24. Lasonder E., Ishihama Y., Andersen J.S., Vermunt A.M., Pain A., Sauerwein R.W., et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 2002, 419:537-542.
25. Xia D., Sanderson S.J., Jones A.R., Prieto J.H., Yates J.R., Bromley E., et al. The proteome of Toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation. Genome Biol 2008, 9:R116.
26. Bocchinfuso D.G., Taylor P., Ross E., Ignatchenko A., Ignatchenko V., Kislinger T., et al. Proteomic profiling of the planarian Schmidtea mediterranea and its mucous reveals similarities with human secretions and those predicted for parasitic flatworms. Mol Cell Proteomics 2012, 11:681-691.
27. Payne S.H., Huang S.T., Pieper R. A proteogenomic update to Yersinia: enhancing genome annotation. BMC Genomics 2010, 11:460.
28. Borchert N., Dieterich C., Krug K., Schutz W., Jung S., Nordheim A., et al. Proteogenomics of Pristionchus pacificus reveals distinct proteome structure of nematode models. Genome Res 2010, 20:837-846.
29. Baudet M., Ortet P., Gaillard J.C., Fernandez B., Guerin P., Enjalbal C., et al. Proteomics-based refinement of Deinococcus deserti genome annotation reveals an unwonted use of non-canonical translation initiation codons. Mol Cell Proteomics 2010, 9:415-426.
30. Pawar H., Sahasrabuddhe N.A., Renuse S., Keerthikumar S., Sharma J., Kumar G.S., et al. A proteogenomic approach to map the proteome of an unsequenced pathogen - Leishmania donovani. Proteomics 2012, 12:832-844.
31. Peri S., Pandey A. A reassessment of the translation initiation codon in vertebrates. Trends Genet 2001, 17:685-687.
32. Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., et al. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol 2003, 21:566-569.
33. Goetze S., Qeli E., Mosimann C., Staes A., Gerrits B., Roschitzki B., et al. Identification and functional characterization of N-terminally acetylated proteins in Drosophila melanogaster. PLoS Biol 2009, 7:e1000236.
34. Arnesen T., Van Damme P., Polevoda B., Helsens K., Evjenth R., Colaert N., et al. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proc Natl Acad Sci U S A 2009, 106:8157-8162.
35. Hollebeke J., Van Damme P., Gevaert K. N-terminal acetylation and other functions of Nalpha-acetyltransferases. Biol Chem 2012, 393:291-298.
36. Mischerikow N., Heck A.J. Targeted large-scale analysis of protein acetylation. Proteomics 2011, 11:571-589.
37. Helbig A.O., Gauci S., Raijmakers R., van Breukelen B., Slijper M., Mohammed S., et al. Profiling of N-acetylated protein termini provides in-depth insights into the N-terminal nature of the proteome. Mol Cell Proteomics 2010, 9:928-939.
38. Holzer T.R., McMaster W.R., Forney J.D. Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana. Mol Biochem Parasitol 2006, 146:198-218.
39. Saxena A., Lahav T., Holland N., Aggarwal G., Anupama A., Huang Y., et al. Analysis of the Leishmania donovani transcriptome reveals an ordered progression of transient and permanent changes in gene expression during differentiation. Mol Biochem Parasitol 2007, 152:53-65.
40. Srividya G., Duncan R., Sharma P., Raju B.V., Nakhasi H.L., Salotra P. Transcriptome analysis during the process of in vitro differentiation of Leishmania donovani using genomic microarrays. Parasitology 2007, 134:1527-1539.
41. Li Q., Zhao Y., Ni B., Yao C., Zhou Y., Xu W., et al. Comparison of the expression profiles of promastigotes and axenic amastigotes in Leishmania donovani using serial analysis of gene expression. Parasitol Res 2008, 103:821-828.
42. Alcolea P.J., Alonso A., Gomez M.J., Sanchez-Gorostiaga A., Moreno-Paz M., Gonzalez-Pastor E., et al. Temperature increase prevails over acidification in gene expression modulation of amastigote differentiation in Leishmania infantum. BMC Genomics 2010, 11:31.
43. El Fakhry Y., Ouellette M., Papadopoulou B. A proteomic approach to identify developmentally regulated proteins in Leishmania infantum. Proteomics 2002, 2:1007-1017.
44. Bente M., Harder S., Wiesgigl M., Heukeshoven J., Gelhaus C., Krause E., et al. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics 2003, 3:1811-1829.
45. Walker J., Vasquez J.J., Gomez M.A., Drummelsmith J., Burchmore R., Girard I., et al. Identification of developmentally-regulated proteins in Leishmania panamensis by proteome profiling of promastigotes and axenic amastigotes. Mol Biochem Parasitol 2006, 147:64-73.
46. McNicoll F., Drummelsmith J., Muller M., Madore E., Boilard N., Ouellette M., et al. A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum. Proteomics 2006, 6:3567-3581.
47. Leifso K., Cohen-Freue G., Dogra N., Murray A., McMaster W.R. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. Mol Biochem Parasitol 2007, 152:35-46.
48. Paape D., Lippuner C., Schmid M., Ackermann R., Barrios-Llerena M.E., Zimny-Arndt U., et al. Transgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes. Mol Cell Proteomics 2008, 7:1688-1701.
49. Paape D., Barrios-Llerena M.E., Le Bihan T., Mackay L., Aebischer T. Gel free analysis of the proteome of intracellular Leishmania mexicana. Mol Biochem Parasitol 2010, 169:108-114.
50. Lahav T., Sivam D., Volpin H., Ronen M., Tsigankov P., Green A., et al. Multiple levels of gene regulation mediate differentiation of the intracellular pathogen Leishmania. Faseb J 2011, 25:515-525.
51. Somanna A., Mundodi V., Gedamu L. In vitro cultivation and characterization of Leishmania chagasi amastigote-like forms. Acta Trop 2002, 83:37-42.
52. Gupta N., Goyal N., Rastogi A.K. In vitro cultivation and characterization of axenic amastigotes of Leishmania. Trends Parasitol 2001, 17:150-153.
53. Biyani N., Madhubala R. Quantitative proteomic profiling of the promastigotes and the intracellular amastigotes of Leishmania donovani isolates identifies novel proteins having a role in Leishmania differentiation and intracellular survival. Biochim Biophys Acta. 2012, 1824:1342-1350.
54. Kelly B.L., Stetson D.B., Locksley R.M. Leishmania major LACK antigen is required for efficient vertebrate parasitization. J Exp Med 2003, 198:1689-1698.
55. Locksley R.M., Pingel S., Lacy D., Wakil A.E., Bix M., Fowell D.J. Susceptibility to infectious diseases: Leishmania as a paradigm. J Infect Dis 1999, 179(Suppl. 2):S305-S308.
56. Jain R., Ghoshal A., Mandal C., Shaha C. Leishmania cell surface prohibitin: role in host-parasite interaction. Cell Microbiol 2010, 12:432-452.
57. Zhu Y., Davis A., Smith B.J., Curtis J., Handman E. Leishmania major CorA-like magnesium transporters play a critical role in parasite development and virulence. Int J Parasitol 2009, 39:713-723.
58. Zhang K., Showalter M., Revollo J., Hsu F.F., Turk J., Beverley S.M. Sphingolipids are essential for differentiation but not growth in Leishmania. EMBO J 2003, 22:6016-6026.
59. Denny P.W., Goulding D., Ferguson M.A., Smith D.F. Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity. Mol Microbiol 2004, 52:313-327.
60. Perez-Victoria J.M., Parodi-Talice A., Torres C., Gamarro F., Castanys S. ABC transporters in the protozoan parasite Leishmania. Int Microbiol 2001, 4:159-166.
61. Ouellette M., Legare D., Papadopoulou B. Microbial multidrug-resistance ABC transporters. Trends Microbiol 1994, 2:407-411.
62. Ouellette M., Fase-Fowler F., Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J 1990, 9:1027-1033.
63. Ouellette M., Hettema E., Wust D., Fase-Fowler F., Borst P. Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania. EMBO J 1991, 10:1009-1016.
64. Callahan H.L., Beverley S.M. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J Biol Chem 1991, 266:18427-18430.
65. Papadopoulou B., Roy G., Dey S., Rosen B.P., Ouellette M. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. J Biol Chem 1994, 269:11980-11986.
66. Legare D., Papadopoulou B., Roy G., Mukhopadhyay R., Haimeur A., Dey S., et al. Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Exp Parasitol 1997, 87:275-282.
67. Papadopoulou B., Roy G., Dey S., Rosen B.P., Olivier M., Ouellette M. Gene disruption of the P-glycoprotein related gene pgpa of Leishmania tarentolae. Biochem Biophys Res Commun 1996, 224:772-778.
68. Mandal G., Sarkar A., Saha P., Singh N., Sundar S., Chatterjee M. Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates. Indian J Biochem Biophys 2009, 46:86-92.
69. Singh N., Almeida R., Kothari H., Kumar P., Mandal G., Chatterjee M., et al. Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray. Parasitology 2007, 134:777-787.
70. Guimond C., Trudel N., Brochu C., Marquis N., El Fadili A., Peytavi R., et al. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res 2003, 31:5886-5896.
71. Augustyns K., Amssoms K., Yamani A., Rajan P.K., Haemers A. Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents. Curr Pharm Des 2001, 7:1117-1141.
72. Romao P.R., Fonseca S.G., Hothersall J.S., Noronha-Dutra A.A., Ferreira S.H., Cunha F.Q. Glutathione protects macrophages and Leishmania major against nitric oxide-mediated cytotoxicity. Parasitology 1999, 118(Pt 6):559-566.
73. Saudagar P., Dubey V.K. Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani. Biol Chem 2011, 392:1113-1122.
74. Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., Ouellette M. Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J 1997, 16:3057-3065.
75. Rochette A., McNicoll F., Girard J., Breton M., Leblanc E., Bergeron M.G., et al. Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania spp. Mol Biochem Parasitol 2005, 140:205-220.
76. Wu Y., El Fakhry Y., Sereno D., Tamar S., Papadopoulou B. A new developmentally regulated gene family in Leishmania amastigotes encoding a homolog of amastin surface proteins. Mol Biochem Parasitol 2000, 110:345-357.
77. Jackson A.P. The evolution of amastin surface glycoproteins in trypanosomatid parasites. Mol Biol Evol 2010, 27:33-45.
78. Teixeira S.M., Kirchhoff L.V., Donelson J.E. Trypanosoma cruzi: suppression of tuzin gene expression by its 5'-UTR and spliced leader addition site. Exp Parasitol 1999, 93:143-151.
79. Cameron P., McGachy A., Anderson M., Paul A., Coombs G.H., Mottram J.C., et al. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol 2004, 173:3297-3304.
80. Padilla A., Noiva R., Lee N., Mohan K.V., Nakhasi H.L., Debrabant A. An atypical protein disulfide isomerase from the protozoan parasite Leishmania containing a single thioredoxin-like domain. J Biol Chem 2003, 278:1872-1878.
81. Ben Achour Y., Chenik M., Louzir H., Dellagi K. Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor. Infect Immun 2002, 70:3576-3585.